SG11201509743WA - Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequence - Google Patents
Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequenceInfo
- Publication number
- SG11201509743WA SG11201509743WA SG11201509743WA SG11201509743WA SG11201509743WA SG 11201509743W A SG11201509743W A SG 11201509743WA SG 11201509743W A SG11201509743W A SG 11201509743WA SG 11201509743W A SG11201509743W A SG 11201509743WA SG 11201509743W A SG11201509743W A SG 11201509743WA
- Authority
- SG
- Singapore
- Prior art keywords
- mhc class
- beta
- promoter sequence
- vectors containing
- lentiviral vectors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13305738 | 2013-06-03 | ||
PCT/EP2014/060740 WO2014195159A1 (fr) | 2013-06-03 | 2014-05-23 | Vecteurs lentiviraux contenant une séquence promotrice amont de microglobuline bêta-2 ou de cmh de classe ii, ou de cmh de classe i |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201509743WA true SG11201509743WA (en) | 2015-12-30 |
Family
ID=48578998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201509743WA SG11201509743WA (en) | 2013-06-03 | 2014-05-23 | Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequence |
Country Status (10)
Country | Link |
---|---|
US (1) | US9657311B2 (fr) |
EP (1) | EP3004361A1 (fr) |
JP (1) | JP2016520316A (fr) |
KR (1) | KR20160011645A (fr) |
CN (1) | CN105683383B (fr) |
AU (1) | AU2014277092B2 (fr) |
BR (1) | BR112015030211A2 (fr) |
CA (1) | CA2913854A1 (fr) |
SG (1) | SG11201509743WA (fr) |
WO (1) | WO2014195159A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3058819B1 (fr) * | 2013-10-18 | 2021-05-19 | Taiho Pharmaceutical Co., Ltd. | Animal non humain exprimant une molécule hla classe i |
WO2016120489A2 (fr) * | 2015-02-01 | 2016-08-04 | Theravectys | Vecteurs lentiviraux pour l'expression d'antigènes de mycobacterium tuberculosis |
US10137144B2 (en) | 2016-01-15 | 2018-11-27 | American Gene Technologies International Inc. | Methods and compositions for the activation of gamma-delta T-cells |
IL310925A (en) | 2016-01-15 | 2024-04-01 | American Gene Tech Int Inc | Methods and preparations for activating GAMMA-DELTA T cells |
US10724052B2 (en) * | 2018-09-07 | 2020-07-28 | Crispr Therapeutics Ag | Universal donor cells |
IT202100011576A1 (it) * | 2021-05-06 | 2022-11-06 | Univ Degli Studi Padova | Nuova sequenza promotore per terapia genica |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU726441B2 (en) * | 1995-08-21 | 2000-11-09 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Methods of assessing MHC class I expression and proteins capable of modulating class I expression |
US20070037165A1 (en) * | 2000-09-08 | 2007-02-15 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
JP2007068473A (ja) * | 2005-09-07 | 2007-03-22 | Yokohama City Univ | Mhc遺伝子の転写因子結合配列を含む発現ベクター |
EP2185192B1 (fr) * | 2007-08-03 | 2018-10-31 | Institut Pasteur | Vecteurs de transfert de gène de lentivirus convenant à une administration répétée et leurs applications médicinales |
EP2385107B1 (fr) * | 2010-05-03 | 2016-08-24 | Institut Pasteur | Composés immunologiques basés sur un vecteur de lentivirus contre le paludisme |
EP2666477A1 (fr) | 2012-05-23 | 2013-11-27 | Theravectys | Vecteurs lentiviraux contenant un promoteur du MHC classe I |
CA3205636A1 (fr) * | 2011-04-20 | 2012-10-26 | University Of Washington Through Its Center For Commercialization | Cellules deficientes en beta-2 microglobuline |
KR101811736B1 (ko) * | 2011-09-26 | 2017-12-22 | 떼라벡띠스 | 렌티바이러스 패키징을 위한 비-서브타입 b gag 단백질의 용도 |
WO2015063708A1 (fr) * | 2013-10-31 | 2015-05-07 | Theravectys | Vecteurs lentiviraux administrés sous forme de vaccins pour induire des réponses immunitaires en cd4+ et cd8+ chez l'homme infecté par le vih-1 |
-
2014
- 2014-05-23 KR KR1020157034528A patent/KR20160011645A/ko not_active Application Discontinuation
- 2014-05-23 WO PCT/EP2014/060740 patent/WO2014195159A1/fr active Application Filing
- 2014-05-23 AU AU2014277092A patent/AU2014277092B2/en not_active Ceased
- 2014-05-23 EP EP14726584.7A patent/EP3004361A1/fr not_active Withdrawn
- 2014-05-23 JP JP2016515755A patent/JP2016520316A/ja active Pending
- 2014-05-23 SG SG11201509743WA patent/SG11201509743WA/en unknown
- 2014-05-23 CA CA2913854A patent/CA2913854A1/fr not_active Abandoned
- 2014-05-23 CN CN201480043991.XA patent/CN105683383B/zh active Active
- 2014-05-23 BR BR112015030211A patent/BR112015030211A2/pt not_active IP Right Cessation
- 2014-05-27 US US14/287,699 patent/US9657311B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20140356946A1 (en) | 2014-12-04 |
KR20160011645A (ko) | 2016-02-01 |
WO2014195159A1 (fr) | 2014-12-11 |
EP3004361A1 (fr) | 2016-04-13 |
AU2014277092B2 (en) | 2019-04-04 |
US9657311B2 (en) | 2017-05-23 |
CN105683383A (zh) | 2016-06-15 |
AU2014277092A1 (en) | 2015-12-10 |
CN105683383B (zh) | 2020-08-21 |
CA2913854A1 (fr) | 2014-12-11 |
JP2016520316A (ja) | 2016-07-14 |
BR112015030211A2 (pt) | 2017-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1250331A1 (zh) | 閉合蛋白-18‧2特異性免疫受體和t細胞表位 | |
DK3083694T3 (da) | Caniniserede, murine anti-canin-pd-1-antistoffer | |
EP3200086A4 (fr) | Dispositif mobile, hmd et système | |
HUE051269T2 (hu) | Lentivírus vektorok | |
IL245907A0 (en) | Stable episomes based on non-integrating vectors from viruses of the halenti family | |
DK2723615T3 (da) | Ulykkesbekæmpelsessystem og køretøj, der indbefatter ulykkesbekæmpelsessystemet | |
ZA201506141B (en) | Flexible conveyance system | |
SG11201509743WA (en) | Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequence | |
EP3036702A4 (fr) | Appareils, procédés et systèmes de recherche de candidats d'abondance | |
EP2969862A4 (fr) | Système de transport flexible | |
GB2556258B (en) | High-performance, low-stress support structure with membrane | |
GB201406997D0 (en) | Flexible cladding, wrap, system and methods | |
HK1211837A1 (en) | Lentiviral vectors containing an mhc class i promoter mhc i | |
EP3362174A4 (fr) | Support de catalyseur | |
IL241898B (en) | Non-phthalate propellants | |
HK1258347A1 (zh) | 用於支持低編碼速率的turbo編碼 | |
EP3364008A4 (fr) | Système de turbo-régénération | |
GB2512346B (en) | Non-phthalate propellants | |
EP3084566A4 (fr) | Appareils, systèmes et procédés de dactylographie | |
EP3233721A4 (fr) | Générateur de gaz à support de catalyseur flottant | |
SG11201605589PA (en) | Device with positioning function, positioning result receiving device, and positioning result utilizing system | |
EP2959150A4 (fr) | Appareils, systèmes et procédés de retard pour fusée | |
FR3001837B1 (fr) | Piece de support de cable, notamment pour aeronef. | |
UA89695U (en) | Lisoverm, complex antiparasitic composition | |
EP3071599A4 (fr) | Anticorps hyper-glycosylés à liaison sélective pour le récepteur fc |